NCT02809404View on ClinicalTrials.gov

Dried Blood SPOT Analysis of Everolimus in Cancer Patients (SPOT-study)

CompletedOBSERVATIONAL
Enrollment

75

Participants

Timeline

Start Date

June 30, 2015

Primary Completion Date

January 31, 2016

Study Completion Date

January 31, 2017

Conditions
Breast CancerRenal Cell Carcinoma
Interventions
DRUG

Everolimus

Trial Locations (1)

Unknown

Radboud university medical center, Nijmegen

All Listed Sponsors
lead

Radboud University Medical Center

OTHER

NCT02809404 - Dried Blood SPOT Analysis of Everolimus in Cancer Patients (SPOT-study) | Biotech Hunter | Biotech Hunter